Discover CME, tools, and guideline-focused education to improve your knowledge - and patient outcomes.
Clear Skin, Clear Path: Transforming Psoriasis Care with Durable Biologic and Oral IL-23 Innovations
June 12, 2026
Denver, Colorado
06:30 PM - 07:30 PM ET
Incorporating Novel Muscarinic Agents for Schizophrenia Into Clinical Practice: Overcoming Clinical Inertia
May 28, 2026 Miami Beach, Florida
Redefining gMG Management: FcRn Antagonists and the New Era of Precision Neurology
September 30, 2026
11:45 AM - 12:45 PM ET
Orlando, Florida
The Future of HNSCC: Aligning Teams, Transforming Care
Ravindra Uppaluri, MD, PhD
Nancy Lee, MD, FASTRO
FcRn: Same Class, Different Paths—Spot Agent Differentiators
Christyn Edmundson, MD
Gil I. Wolfe MD, FAAN
Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
May 28, 2026
07:00 AM - 08:00 AM ET
Turning Flares Into Function: Flag Uncontrolled Disease
Minimal By Design: Define MSE Endpoints
Treat. Target. Transform: Applying Treat-to-Target Principles in the Management of Generalized Myasthenia Gravis (gMG)
The IgG Clock: Redose Using IgG Kinetics
Shared Goals, Shared Gains: Align With Patient Preferences
Inside the 4 Hits: Targeting APRIL to Change the Course of IgAN
Richard Lafayette, MD, FACP
Dana Rizk, MD
Hong Zhang
Suzuki Yusuke, MD, PhD
APRIL Uncovered: An Upstream Driver in IgAN
Mechanism-Based Targeting: Why APRIL Matters in IgAN
Retina Rumble: Debating Modern Treatment Options
Roger A. Goldberg, MD, MBA
Christina Y. Weng, MD, MBA, FASRS
Yasha S. Modi, MD
Seeing the Invisible: Radiologic Precision to Enable Early Intervention in Bronchiectasis
May 13, 2026
06:00 PM - 07:00 PM ET
Escalate With Intention: Stepwise, Target-Anchored Moves
Shifting the Script: Personalizing Overactive Bladder Treatment in Complex Patients
David Staskin, MD
Matt T. Rosenberg, MD
Kennedy Koebbe, MSN, RN
Emerging Evidence: IgAN Disease-Modifying Agents
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.